J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM

Watchlist Manager
J B Chemicals and Pharmaceuticals Ltd Logo
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Watchlist
Price: 1 859.7 INR -1.7% Market Closed
Market Cap: 289.2B INR
Have any thoughts about
J B Chemicals and Pharmaceuticals Ltd?
Write Note

Operating Margin
J B Chemicals and Pharmaceuticals Ltd

22%
Current
20%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
22%
=
Operating Profit
8.1B
/
Revenue
37.1B

Operating Margin Across Competitors

Country IN
Market Cap 288.6B INR
Operating Margin
22%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 756.3B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 2.7T DKK
Operating Margin
44%
Country US
Market Cap 349.7B USD
Operating Margin
28%
Country US
Market Cap 251.6B USD
Operating Margin
34%
Country CH
Market Cap 199.5B CHF
Operating Margin
32%
Country UK
Market Cap 161.6B GBP
Operating Margin
21%
Country CH
Market Cap 171.3B CHF
Operating Margin
31%
Country US
Market Cap 151.4B USD
Operating Margin
22%
No Stocks Found

J B Chemicals and Pharmaceuticals Ltd
Glance View

Market Cap
288.6B INR
Industry
Pharmaceuticals

In the bustling marketplace of India's pharmaceutical industry, J B Chemicals and Pharmaceuticals Ltd. has carved its niche, a testament to its strategic vision and operational prowess. Founded in 1976 by Janak Mehta, the company has grown from its humble beginnings into a leading player in both the domestic and international arenas. Originally rooted in the ethos of quality and innovation, it established a firm foothold in the pharmaceutical sector through a diverse portfolio that includes formulations, active pharmaceutical ingredients (APIs), and contract manufacturing. As a vertically integrated company, J B Chemicals leverages its ability to control the manufacturing process from start to finish, ensuring strict quality measures and cost efficiencies, vital in tackling industry competition and regulatory challenges. The heart of J B Chemicals’ revenue model is its well-rounded product line that spans a range of therapeutic categories, including gastrointestinal, cardiovascular, and anticold segments. Blockbuster brands like Cilacar and Metrogyl have propelled the company to the top ranks within India, while its export division flourishes, contributing significantly to total earnings. With footprints in more than 30 countries, particularly in Russia and South Africa, the company taps into the growing demand for generic medicines worldwide. Moreover, by embracing innovation and investing in research and development, J B Chemicals continues to introduce new and improved medical solutions, positioning itself as a dynamic player in meeting global healthcare needs.

JBCHEPHARM Intrinsic Value
1 252.85 INR
Overvaluation 33%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
22%
=
Operating Profit
8.1B
/
Revenue
37.1B
What is the Operating Margin of J B Chemicals and Pharmaceuticals Ltd?

Based on J B Chemicals and Pharmaceuticals Ltd's most recent financial statements, the company has Operating Margin of 22%.